Inventor · disambiguated record
William R. Schief
Also filed as: SCHIEF JR WILLIAM RAY · SCHIEF WILLIAM · SCHIEF WILLIAM R · SCHIEF WILLIAM RAY
14 granted patents·11 pending applications·35 citations·filing 2007–2025
88Inventor score
Files withSCRIPPS RESEARCH INST4INT AIDS VACCINE INITIATIVE3INT AIDS VACCINE INITIATIVE INC3KWONG PETER D2MASCOLA JOHN R2
Top patents by PatentIndex Score
25 records- 0193US8637036B2Neutralizing antibodies to HIV-1 and their useMASCOLA JOHN R·Filed 2012·Granted Jan 28, 2014·22 cites·23 claims
- 0285US9738703B2Neutralizing antibodies to HIV-1 and their useUS HEALTH·Filed 2015·Granted Aug 22, 2017·2 cites·21 claims
- 0384US9175070B2Neutralizing antibodies to HIV-1 and their useMASCOLA JOHN R·Filed 2010·Granted Nov 3, 2015·4 cites·7 claims
- 0480US10035845B2Neutralizing antibodies to HIV-1 and their useUS HEALTH·Filed 2017·Granted Jul 31, 2018·2 cites·21 claims
- 0578US10221217B2Engineered outer domain (eOD) of HIV gp120 and mutants thereofUNIV OF WASHINGTON CENTER FOR COMMERCIALIZATION·Filed 2015·Granted Mar 5, 2019·3 cites·2 claims
- 0677US12281142B2Recombinant HIV Env polypeptides and their useINT AIDS VACCINE INITIATIVE INC·Filed 2021·Granted Apr 22, 2025·1 cites·16 claims
- 0766US10421789B2Engineered outer domain (EOD) of HIV GP120 and mutants thereofUNIV OF WASHINGTON CENTER FOR COMMERCIALIZATION·Filed 2019·Granted Sep 24, 2019·0 cites·20 claims
- 0864US11203617B2Immunogenic trimersINT AIDS VACCINE INITIATIVE·Filed 2018·Granted Dec 21, 2021·1 cites·7 claims
- 0961US2012034254A1Antigenic cloaking and its useKWONG PETER D·Filed 2009·Application pending·0 cites
- 1059US11224648B2Antigen-adjuvant coupling reagents and methods of useMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Jan 18, 2022·0 cites·26 claims
- 1158US9701720B2Epitope-scaffold immunogens against respiratory syncytial virus (RSV)UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2013·Granted Jul 11, 2017·0 cites·7 claims
- 1256US2024123046A1Immunogenic compositionsSCRIPPS RESEARCH INST·Filed 2021·Application pending·0 cites
- 1356US2014322269A1Engineered outer domain (eod) of hiv gp120 and mutants thereofUNIV WASHINGTON·Filed 2014·Application pending·0 cites
- 1450US2023016284A1Immunogenic trimersINT AIDS VACCINE INITIATIVE INC·Filed 2021·Application pending·0 cites
- 1548US12496336B2Peptide vaccine based on a new universal influenza a hemagglutinin head domain epitope and human monoclonal antibodies binding theretoUNIV VANDERBILT·Filed 2020·Granted Dec 16, 2025·0 cites·27 claims
- 1648US11248027B2Engineered outer domain (eOD) of HIV GP120, mutants and use thereofINT AIDS VACCINE INITIATIVE·Filed 2017·Granted Feb 15, 2022·0 cites·5 claims
- 1747US9718862B2Polypeptides and their use in treating and limiting respiratory syncytial virus infectionSCHIEF WILLIAM R·Filed 2011·Granted Aug 1, 2017·0 cites·19 claims
- 1846US2024226272A9Immunogenic compositionsSCRIPPS RESEARCH INST·Filed 2021·Application pending·0 cites
- 1945US2010068217A1Epitope-transplant scaffolds and their useKWONG PETER D·Filed 2007·Application pending·0 cites
- 2043US2024247033A1Sars-cov-2 rbd constructsSCRIPPS RESEARCH INST·Filed 2021·Application pending·0 cites
- 2142US2014348865A1Immunogens based on an hiv-1 v1v2 site-of-vulnerabilityUS OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SER·Filed 2012·Application pending·0 cites
- 2241US2012315270A1Rsv immunogens, antibodies and compositions thereofMCLELLAN JASON S·Filed 2010·Application pending·0 cites
- 2340US2015044248A1Polypeptides and their use in treating metapneumovirus (mpv) infectionSCRIPPS RESEARCH INST·Filed 2013·Application pending·0 cites
- 2437US2025250306A1Immunogenic proteins and nucleic acids encoding the sameINT AIDS VACCINE INITIATIVE INC·Filed 2025·Application pending·0 cites
- 2527US9707290B2Immunogens of HIV-1 broadly neutralizing antibodies, methods of generation and uses thereofINT AIDS VACCINE INITIATIVE·Filed 2015·Granted Jul 18, 2017·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when William R. Schief files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →